ClinicalTrials.gov
ClinicalTrials.gov Menu

Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00110422
Recruitment Status : Completed
First Posted : May 10, 2005
Last Update Posted : April 15, 2011
Sponsor:
Collaborator:
Sanofi
Information provided by:
Bristol-Myers Squibb

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2007
  Actual Study Completion Date : February 2007
  Certification/Extension First Submitted : February 15, 2010